Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Conditions

• Type 2 Diabetes Mellitus

Interventions

• DRUG: Saxagliptin 5 mg
• DRUG: Placebo 5 mg for Saxagliptin
• DRUG: Placebo 500 mg for metformin (with titration)
• DRUG: Metformin 500 mg with titration

Sponsor

AstraZeneca